Stockscreener 앱 받기
0.015
7.14%
0.0010
전일 마감가:
$0.014
열려 있는:
$0.0141
하루 거래량:
7,635
Relative Volume:
0.17
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+7.14%
1개월 성능:
-24.24%
6개월 성능:
+25.00%
1년 성능:
-41.63%
1일 변동 폭
$0.014
$0.015
1주일 범위
$0.014
$0.0169
52주 변동 폭
$0.0009
$0.0698
Nls Pharmaceutics Ag Stock (NLSPW) Company Profile
명칭
Nls Pharmaceutics Ag
전화
41 44 512 21 50
주소
The Circle 6, Zurich
NLSPW을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NLSPW
Nls Pharmaceutics Ag
|
0.015 | 0 | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Nls Pharmaceutics Ag 주식(NLSPW)의 최신 뉴스
Can trapped investors hope for a rebound in NLS Pharmaceutics AGAI Stock Movement Forecast with Accuracy - Newser
What machine learning models say about NLS Pharmaceutics AG Equity WarrantPrice Movement and Market Sentiment Analysis - Newser
Using data models to predict NLS Pharmaceutics AG stock movementFree Low Risk Buy Zone Opportunity Watch - Newser
Will NLS Pharmaceutics AG Equity Warrant stock recover after recent dropWeekly Stock Picks with Trend Confidence - Newser
How to escape a deep drawdown in NLS Pharmaceutics AGConservative Asset Allocation Risk Analysis - Newser
Why NLS Pharmaceutics AG Equity Warrant stock attracts strong analyst attentionMarket Liquidity and Price Flow Analysis - Newser
NLS Pharmaceutics Regains Compliance With Nasdaq Stockholders' Equity Requirement - 富途牛牛
Building trade automation scripts for NLS Pharmaceutics AGFree Wealth Building Stock Market Ideas - Newser
How to escape a deep drawdown in NLS Pharmaceutics AG Equity WarrantPattern Breakout Prediction for Short Term - Newser
Custom watchlist performance reports with NLS Pharmaceutics AGFree Trade Insight With Community Collaboration - Newser
Chart based exit strategy for NLS Pharmaceutics AG Equity WarrantAI Screener Based Stock Summary Report - Newser
NLS Pharmaceutics (NASDAQ:NLSP) Rating Increased to Hold at Wall Street Zen - Defense World
Heatmap analysis for NLS Pharmaceutics AG and competitorsFree AI Driven Buy Alert Trade Blueprint - Newser
Is NLS Pharmaceutics AG Equity Warrant still worth holding after the dipForecasting Stock Moves with AI Insights - Newser
Can technical indicators confirm NLS Pharmaceutics AG’s reversalRSI and MACD Signal Summary with Trends - Newser
Volume spikes in NLS Pharmaceutics AG stock – what they meanBuy Signal System Based on Price Action - Newser
Risk adjusted return profile for NLS Pharmaceutics AG Equity Warrant analyzedHigh Probability Trade Outcome Prediction - Newser
Does NLS Pharmaceutics AG Equity Warrant stock pay reliable dividendsTechnical Confirmation System with Signal Alerts - Newser
Developing predictive dashboards with NLS Pharmaceutics AG Equity Warrant dataFree Weekly Setup With 3x Return Potential - Newser
Candlestick signals on NLS Pharmaceutics AG stock todayFree Daily Growth Stock Pick Reports - Newser
Measuring NLS Pharmaceutics AG Equity Warrant’s beta against major indicesFree AI Based High Gain Watchlist Scanner - Newser
Analyzing net buyer seller activity in NLS Pharmaceutics AGMomentum Screener with Buy and Sell Areas - Newser
Long term hold vs stop loss in NLS Pharmaceutics AG Equity WarrantLong-Term Growth Trend Summary With Confidence - Newser
Analyzing NLS Pharmaceutics AG with multi timeframe chartsFree Early Entry Tips With Low Risk Zone - Newser
Can momentum traders help lift NLS Pharmaceutics AG Equity WarrantLow Risk Stock Trade Opportunity Analysis - Newser
Why NLS Pharmaceutics AG stock attracts strong analyst attentionFree Early Entry Tips With Low Risk Zone - Newser
How NLS Pharmaceutics AG stock performs during market volatilityFree High Yield Stock Screening Results - Newser
Analysts Apply Wyckoff Model to NLS Pharmaceutics AG StockWatchlist for Low Risk High Return Stocks Updated - metal.it
When is NLS Pharmaceutics AG stock expected to show significant growthFree Stock Selection - Jammu Links News
Is NLS Pharmaceutics AG a good long term investmentMaximize gains with timely market signals - Jammu Links News
How does NLS Pharmaceutics AG Equity Warrant generate profit in a changing economyBuild wealth with reliable stock picks - Jammu Links News
Should I hold or sell NLS Pharmaceutics AG stock in 2025Achieve breakthrough financial results today - Jammu Links News
What is the risk reward ratio of investing in NLS Pharmaceutics AG Equity Warrant stock - Jammu Links News
How does NLS Pharmaceutics AG Equity Warrant compare to its industry peersCapitalize on momentum-driven stocks - Jammu Links News
Nls Pharmaceutics Ag (NLSPW) 재무 분석
Nls Pharmaceutics Ag (NLSPW)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):